Stoke Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Stoke Therapeutics, Inc. is a biotechnology company focused on treating severe genetic diseases by precisely upregulating protein expression. The company uses its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach to develop therapies for diseases caused by haploinsufficiency. Stoke is developing treatments for conditions including Dravet syndrome and autosomal dominant optic atrophy.